Cotterill S
Microbiology Department, City Hospital NHS Trust, Birmingham, UK.
J Antimicrob Chemother. 1995 Nov;36(5):773-80. doi: 10.1093/jac/36.5.773.
Continuous haemo(dia)filtration techniques as a means of extracorporeal renal replacement therapy are being used more and more, especially on intensive care units. The effect of intermittent haemodialysis on the pharmacokinetics of systemic antibiotics is well documented and advice is provided in the drug data sheets regarding dosage, timing and additional doses (post haemodialysis). Continuous haemofiltration significantly alters the handling of these same antibiotics compared with haemodialysis, such that if the advice given for 'haemodialysis' is used for patients on haemofiltration, under-dosing the patient may lead to sub-therapeutic antibiotic levels. The reasons for these differences are discussed and suggested dosage modifications are given for commonly used antimicrobials based on available published data.
连续血液(透析)滤过技术作为体外肾脏替代治疗的一种手段,正越来越多地被使用,尤其是在重症监护病房。间歇性血液透析对全身性抗生素药代动力学的影响已有充分记录,药品说明书中也提供了关于剂量、给药时间和额外剂量(血液透析后)的建议。与血液透析相比,连续血液滤过显著改变了这些相同抗生素的处理方式,因此,如果将针对“血液透析”给出的建议用于接受血液滤过的患者,用药剂量不足可能导致抗生素水平低于治疗剂量。文中讨论了这些差异的原因,并根据现有已发表数据,针对常用抗菌药物给出了建议的剂量调整。